
Cagent Vascular and 3comma Medical Announce Strategic Partnership to Expand International Distribution of Serranator Product Family in EU and MENA Regions
Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced its strategic partnership with 3comma Medical GmbH, a commercial services firm that specializes in bringing innovative medical device products to international markets. Under this collaboration, 3comma will serve as the exclusive international (OUS) distributor in EU and MENA regions for Cagent Vascular, leveraging its extensive network, industry expertise, and market insights to expedite the adoption of the Serranator® PTA Serration Balloon Product Family. This expansion builds upon the company's commercial success and growth in the US market. The Serranator is a groundbreaking therapy for the treatment of peripheral artery disease (PAD) and chronic limb threatening ischemia (CLTI).
'We are excited to join forces with 3comma to accelerate adoption in international markets,' said Paul Wilson, Chief Commercial Officer of Cagent Vascular. 'Partnering with 3comma marks an exciting step forward in expanding global access to the Serranator portfolio and delivering cutting-edge solutions to patients around the world. 3comma's deep commercial experience with peripheral vascular products and quality service will strengthen our commercial efforts to ensure we maximize growth opportunities and rapidly scale our presence to match international demand.' Mr. Wilson added, 'We're especially excited to make Serranator more accessible to physicians, providing them with a better tool to enhance patient care and drive improved outcomes. '
Marc Paris, CEO and Managing Partner of 3comma, expressed enthusiasm about the partnership: 'We are thrilled to partner with Cagent Vascular and bring Serranator to physicians worldwide. Cagent's commitment to delivering high-quality products for the treatment of PAD and CLTI will be a valuable addition to the institutions we serve. By combining our comprehensive distribution capabilities with Cagent's innovative offerings, we aim to optimize PAD and CLTI treatment across the globe.'
Advancing Vascular Care with Innovative Serration Technology
Cagent Vascular remains committed to advancing vascular care by delivering high-quality, clinically effective solutions that improve patient outcomes. The company's proprietary serration balloon technology is designed to optimize vessel preparation, enhance arterial expansion, and address challenging lesion morphologies in peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI).
The Serranator ® and Serranator SL-PRO™ PTA Serration Balloon Catheters are FDA-cleared, novel balloons using stainless steel micro-serration technology, designed to create linear, interrupted scoring along the endoluminal surface. With 1,000x more point force compared with plain-old balloon angioplasty, serration occurs during slow-and-low balloon inflation and is designed to aid arterial expansion, effectively achieving luminal gain in all lesion morphologies with minimal recoil. By bringing a differentiated approach to vessel preparation, Cagent Vascular continues to support physicians in delivering optimal outcomes for patients with PAD and CLTI.
SOURCE: Cagent Vascular
Copyright Business Wire 2025.
PUB: 04/03/2025 09:41 AM/DISC: 04/03/2025 09:41 AM
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
a day ago
- Business Wire
SBC Medical added to membership of Russell 3000 ® Index
IRVINE, Calif.--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical'), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000 ® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. Membership in the Russell 3000 ® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000 ® Index or small-cap Russell 2000 ® Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to FTSE Russell, the global index provider. Fiona Bassett, CEO of FTSE Russell, An LSEG Business, comments: 'The Russell indexes have continuously adapted to the evolving dynamic US economy, and it's crucial to fully recalibrate the suite of Russell US Indexes, ensuring the indexes maintain an accurate representation of the market. The transition to a semi-annual reconstitution frequency from 2026 will ensure our indexes continue to represent the market and maintain the purpose of the index as a portfolio benchmark.' For more information on the Russell 3000 ® Index and the Russell indexes reconstitution, go to the 'Russell Reconstitution' section on the FTSE Russell website. About SBC Medical SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit About FTSE Russell, an LSEG Business FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives. A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as it seeks to enhance the breadth, depth and reach of its offering. FTSE Russell is wholly owned by London Stock Exchange Group. For more information, visit FTSE Russell. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at

Business Insider
a day ago
- Business Insider
AI is helping small businesses increase productivity. Here's a look inside the computing hardware helping power it.
Businesses across industries are increasing their AI usage. AI workloads require hardware equipped with powerful processors that can handle these tasks. Responsible and sustainable AI adoption is key to business success. Most tech-savvy observers understand that AI is transforming large enterprises across functions such as customer service, HR, and the supply chain. Chatbots and virtual assistants are now powered by large language models (LLMs) that respond to nearly any natural-language query. These models are trained on business-specific data to provide targeted, accurate answers. According to a poll from the US Chamber of Commerce and Teneo, 98% of small businesses now use AI-enabled software, and 40 % of them employ generative tools like chatbots and image creators to cut costs and speed workflows. But AI isn't just making a splash at big corporations: a new generation of everyday business hardware and operating systems is putting AI in the hands of business owners of all sizes, with applications across a wide range of business functions. Business computing systems for the AI era Andrew Wan, product manager at MSI, has a front-row seat to the transformative impact of AI across industries. He explains that what was once a buzzword is now a practical, everyday tool. In fact, 91% of SMBs that have adopted AI say it's driven measurable revenue growth, according to a survey of 3,350 business leaders from Salesforce. For example, in marketing, AI is powering smarter, more personalized campaigns. Content teams are creating, tweaking, and repurposing material at incredible speeds. Meanwhile, in law, AI is cutting down the time needed for research and contract reviews. The classroom and the clinic are also seeing significant benefits. In education, AI is making learning more flexible, while In healthcare, AI is improving diagnoses and patient care. Across fields, AI boosts productivity and enables people to focus on the work that really matters. AI-ready computing hardware Many business owners have questions about the suitability of their legacy systems in this new AI era. According to Wan, MSI's latest technology is designed to help everyday business users take full advantage of AI. The Cubi NUC AI+ 2M, for example, include the next-generation Intel® Lunar Lake processors, featuring on-chip NPU and GPU cores which provide efficient, on-device AI computing. These compact systems also include Microsoft Copilot+, an AI-powered assistant designed to help teams work smarter. And it's not just enthusiasts leveraging AI: 27% of SMBs have "significantly accelerated" tech spending because of AI needs, with another 35% "slightly accelerating" their investments — underscoring why on-device NPUs and GPUs are so critical. MSI's new desktop models also come with Windows 11 Pro pre-installed, offering businesses a smoother upgrade path from Windows 10 as Microsoft's October migration deadline looms. A real business impact AI is already improving productivity and business outcomes at many organizations. Early adopters in small and mid-sized businesses are seeing real gains by automating repetitive workflows that free up valuable time and resources. "We're hearing about tangible improvements in productivity, customer satisfaction, and even employee engagement as teams are empowered by technology that supports their goals," Wan said. Although AI has already had a profound impact on businesses, Wan believes we've only scratched the surface of its potential. Over the next year, he expects AI to become even more embedded in everyday workflows, especially through smart devices that offer real-time insights while keeping data private and secure. "Fast forward five years, and AI won't just be a helpful tool — it'll be at the heart of how businesses run," he said. "It'll shape strategies, spark new revenue ideas, and open doors to ways of working we haven't even imagined yet. The companies that start laying the groundwork now with AI-friendly systems will be the ones setting the pace in this smarter, more connected future." AI for good Of course, for all of the opportunities AI affords businesses, there are also a number of risks to watch out for. Wan says MSI is committed to responsible adoption of AI, and its suite of AI-powered computing products have been designed with sustainability in mind. "We've built in a three-year Advance Replacement Warranty, which means virtually zero downtime," Wan said. "And by focusing on energy-efficient design, we're helping businesses reduce their environmental footprint while embracing the future of work." 77% of small businesses plan to adopt new digital technologies — including AI and even metaverse tools — within the next year, making energy-efficient hardware and robust warranties like MSI's Advance Replacement critical for minimizing both downtime and environmental impact. "As we build toward a more intelligent future, we believe it's just as important to build a more sustainable one," Wan said.


Business Wire
2 days ago
- Business Wire
Align Technology Connects With Over 2,000 Doctors and Practice Staff at the 2025 Invisalign ® Asia Pacific (APAC) Summit
BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2025 Invisalign ® Asia Pacific ('APAC') Summit held in Bangkok, Thailand, June 5 – 7, 2025. 'With more than 3 million Invisalign smiles across Asia Pacific, we know that this region sees some of the toughest clinical challenges in the field of dentistry,' said David Carr, Align executive vice president and managing director, APAC. 'The 2025 Invisalign Asia Pacific Summit underscores the importance of continued innovation and education. We are committed to working in partnership with doctors across the region in developing Invisalign treatment protocols that can help them transform smiles and change lives for even more patients.' Over three days, more than 2,000 doctors, practice team members, partners, and Align staff from across the region came together to explore the latest innovations in digital orthodontics and restorative dentistry. The summit featured over 60 expert speakers and more than 50 immersive breakout lectures and hands-on workshops, all designed to help doctors elevate clinical outcomes, streamline workflows, and grow their practices. Key topics covered include kids and teen, complex treatments, comprehensive dentistry and practice growth. 'This meeting provided us with a platform to connect with doctors across the full Asia Pacific region, encourage ongoing learning and sharing and showcase how our global innovations can support doctors in this market,' said Gigi Tsui, Align senior director, clinical, APAC. 'As we celebrate 20 million Invisalign smiles globally, including 3 million Invisalign smiles across the Asia Pacific region, it's critical that we continue to engage doctors for feedback and insights. This is fundamental to developing new innovations that meet the unique needs of doctors and patients across this region.' Attendees explored new developments across multiple interactive zones in the Innovation Hub, including: Kids and Teens: Featuring Invisalign First™, Invisalign® Palatal Expander System, and Invisalign® System with mandibular advancement featuring occlusal blocks ('MAOB'). ClinCheck® signature experience: Highlighting the 1-page Rx form (Flex Rx), preference templates, and ClinCheck ® Live Update. Comprehensive Dentistry: Showcasing iTero Lumina™ Pro dental imaging system, iTero™ intraoral scanner, Invisalign Smile Architect™, and Invisalign® Smile Video. Consumer & Branding: Demonstrating branding and tools to help doctors raise awareness of digital treatment options among patients of all ages. Clinical Excellence: Sharing clinical tools, evidence-based resources, education and insights available to doctors and staff. The summit also featured a Women Leadership session and provider recognition and lifetime achievement awardees. In addition to the core Asia Pacific Invisalign Summit, over 300 delegates across 78 universities also attended the Align APAC University Forum hosted at the renowned Chulalongkorn University in Bangkok. The forum served as a dynamic platform for cross-border collaboration and meaningful dialogue on how Align's evidence-based approach and cutting-edge innovations complements academic excellence and clinical training. Key highlights included keynote presentations by industry experts, interactive case-based discussions, resident showcases, and panels on integrating aligner therapy into university curriculum. The event also celebrated academic excellence with the APAC Case Challenge and Align research awards for APAC, while fostering peer-to-peer collaboration and inspiring the next generation of orthodontic leaders. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.